twitter
en POLSKI
eISSN: 2719-3209
ISSN: 0023-2157
Klinika Oczna / Acta Ophthalmologica Polonica
Current issue Archive Videos Articles in press About the journal Supplements Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
2/2018
vol. 120
 
Share:
Share:
abstract:
Review paper

Macular teleangiectasia – a diagnostic and therapeutic challenge

Katarzyna Kozicka
,
Izabella Karska-Basta
,
Bożena Romanowska-Dixon

Online publish date: 2018/10/25
View full text Get citation
 
PlumX metrics:
Macular telangiectasia denotes a group of diseases of unclear cause which involve changes to retinal blood vessels. Based on ophthalmoscopy, fluorescein angiography and optical coherence tomography findings, we can distinguish type 1 and type 2 macular teleangiectasia. Type 1 is usually a unilateral dilatation of vessels in the parafoveal region with microaneurysms. It typically affects young males with macular oedema causing visual loss. The course is mild, and the prognosis is good. Type 2 affects men and women equally. It is characterised by abnormalities in perimacular blood vessels, which cause hyperplasia of retinal pigment epithelium. It is bilateral and vision loss is caused by the loss of Müller cells. The prognosis is poor. Treatment of macular teleangiectasia depends on its type. In type 1, the most common treatment is laser photocoagulation of leakage areas within the retina. In type 2, as a neurodegenerative process, there is no effective treatment so far.
keywords:

macular teleangiectasia, optical coherence tomography, laser photocoagulation

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.